Vistin Pharma ASA: Mandatory notification of trade

Magnus Tolleshaug, Chief Executive Officer in Vistin Pharma ASA, and a primary insider, has on 20'th of February 2026 purchased 30.000 shares in Vistin Pharma ASA at an average price of NOK 21,10 per share. Following this purchase Magnus Tolleshaug holds 105.000 shares in Vistin Pharma ASA.

Attachment

• Notification of trade_skjema - Magnus Tolleshaug

You May Also Be Interested In

• U.S. P&C Insurers Post Strong Underwriting Gains Through First Half of 2026; Line-Specific and Geographic Challenges Persist
• Important Notice to Long-Term Shareholders of Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); Insulet Corporation (NASDAQ: PODD); and York Space Systems Inc. (NYSE: YSS): Grabar L
• Fluent, Inc. to Participate in 19th Annual Barrington Research Virtual Fall Investment Conference